1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding siteA caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosisA comparison of heparin strategies after thrombolytic therapyA decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis.A direct comparison of prophylactic low-molecular-weight heparin versus unfractionated heparin in neurosurgery: A meta-analysisA meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequencyA meta-analysis of effects of heparin flush and saline flush: quality and cost implicationsA meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophiliaA protamine-coated device for the control of heparin anticoagulationA review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolismA systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolismA systematic review of heparin to treat burn injuryAbnormal serum free thyroid hormone levels due to heparin administrationActions and Interactions of Antithrombin and HeparinActions of heparin that may affect the malignant processActivated clotting times, heparin responses, and antithrombin: have we been wrong all these years?Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and RecommendationsActive conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solutionAcute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopeniaAcute ischemic stroke and heparin treatmentsAcute pancreatitis owing to very high triglyceride levels treated with insulin and heparin infusion.Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient With ST-Segment Elevation Myocardial InfarctionAdding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysisAdjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.Adjunctive low molecular weight heparin during fibrinolytic therapy in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.Advanced nanocarriers based on heparin and its derivatives for cancer managementAdvances in the separation, sensitive detection, and characterization of heparin and heparan sulfateAerosolized heparinAllergy to heparin, heparinoids, and recombinant hirudin. Diagnostic and therapeutic alternativesAlternatives to standard unfractionated heparin for pediatric hemodialysis treatmentsAlternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypassAlzheimer's disease: another target for heparin therapy.An alternative view of heparin anticoagulation in acute focal brain ischemiaAn overview of clinical trials of low molecular weight heparin fractions.An overview of potential applications of heparin in vitreoretinal surgery.An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary interventionAnalysis and characterization of heparin impuritiesAnother bleeding heart: perioperative heparin management revisitedAnti-cancer properties of low-molecular-weight heparin: preclinical evidence
about
type
label
Generic instance
@en